Pharmacodynamics and Pharmacokinetics of Combined Use of Rosuvastatin (Crestor) and Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients With Hyperlipidemia (ROSALKA)
Phase of Trial: Phase II
Latest Information Update: 20 May 2008
At a glance
- Drugs Lopinavir/ritonavir; Rosuvastatin
- Indications HIV infections; Hyperlipidaemia
- Focus Pharmacokinetics
- 21 Aug 2007 Status changed from in progress to completed.
- 18 Nov 2005 New trial record.